EXCLUSIVE: Tilray CEO Talks Symbios, Aphria, Market Opportunities On 'Power Hour'

Tilray Inc TLRY recently announced the launch of Symbios, a medical cannabis brand the cannabis company said will provide a broader spectrum of formats and unique cannabinoid ratios at a better price point.

CEO Irwin Simon appeared on Benzinga's YouTube show "Power Hour" for an exclusive interview Wednesday.

Symbios means plant and health, the Tilray CEO told Benzinga. The company wanted to launch a brand that offered high quality medical products at lower prices, he said. Tilray plans to continue to launch brands within its own business where it makes sense to do so.

The cannabis company has an incredible footprint in the Canadian market and is excited about the potential reach it can have in the U.S. upon legalization there, the CEO said.

Simon On Tilray + Aphria: Simon was the chairman and CEO of Aphria leading up to its reverse merger with Tilray, at which point he was selected to lead the combined company, which operates under the name Tilray.

The merger gave the combined company more access to distribution in Europe, a stronger portfolio of brands and a stronger balance sheet, Simon said.

Tilray is now one of the largest cannabis companies in the world on a revenue basis, he said.

Simons's interview begins around the 28:20 mark

Tilray's Market Opportunity: The cannabis industry is a $100-billion industry with tremendous opportunities spanning adult-use, medical cannabis and consumable goods, Simon said. 

The cannabis CEO has a consumer packaged goods background and aims to build Tilray into a consumer packaged goods business, he said.

The availability and process of buying CBD- and THC-infused drinks will eventually be similar to that of alcoholic drinks, Simon said.

The company acquired Sweetwater Brewing Company to ensure it will have ample research and development skills, as well as eventual manufacturing and distribution capabilities, the CEO told Benzinga.

TLRY Price Action: Tilray has traded as high as $67 and as low as $4.41 over a 52-week period.

At last check Wednesday, the stock was up 12.39% at $22.72.

Before leaving Simon talked about his personal background and family life. "I wish my kids had my upbringing, and I wish I had my kids' upringing." 

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisTop StoriesMarketsMoversTrading IdeasInterviewIrwin SimonPower HourSymbios
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!